OT I'd be happy to lose my entire AVXL investment
Post# of 72440
By the way, I think that AVXL has made a very good move by trying to diversify their drug applications. They have that Michael J. Fox grant to investigate it for Parkinson's, and also they are hopeful of having a better epileptic seizure drug. So AVXL will take a huge hit if these other guys succeed in getting to human trials quickly and show signs of efficacy -- but there still should be value in the company.